AVCNF (AVCNF) Stock Price & Analysis
AVCNF (AVCNF) fell 3.50% to USD 0.08 as of June 10, 2026 at 05:28 UTC, according to Nexqual real-time market data.
AVCNF last closed at USD 0.08; the session ranged USD 0.08–0.08 on volume of 32,000 shares. Market capitalization is $10.06M, with a 52-week range of USD 0.08–0.24 (OQX). Source: Nexqual, June 10, 2026 at 05:28 UTC.
Key Statistics (as of June 10, 2026 at 05:28 UTC)
| Price | USD 0.08 |
|---|---|
| Change | ▼ 3.50% (down) |
| Previous Close | USD 0.08 |
| Open | USD 0.08 |
| Day Range | USD 0.08 – 0.08 |
| 52-Week Range | USD 0.08 – 0.24 |
| Volume | 32,000 shares |
| Market Cap | $10.06M |
| Exchange | OQX |
Technical Analysis (AVCNF)
Nexqual's technical model rates AVCNF "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:28 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.85 (neutral) |
| vs SMA50 | Below (USD 0.1) |
| MACD | -0.01 (negative) |
Analyst Ratings (AVCNF)
Wall Street analysts rate AVCNF "None", per Nexqual as of June 10, 2026 at 05:28 UTC.
| Consensus Rating | None |
|---|
Earnings (AVCNF)
| Next Earnings Date | 2026-08-12 |
|---|
Source: Nexqual, June 10, 2026 at 05:28 UTC.
Financials & Fundamentals (AVCNF)
| Total Revenue | $25.83M |
|---|---|
| Revenue Growth (YoY) | +5.60% |
| Gross Margin | +53.24% |
| Operating Margin | -4.63% |
| Profit Margin | -12.09% |
| ROE | -26.45% |
| Current Ratio | 0.96 |
| Total Cash | $372,103 |
| Total Debt | $0 |
| Free Cash Flow | $-1.39M |
Source: Nexqual, June 10, 2026 at 05:28 UTC.
Financial Health Score (AVCNF)
Nexqual rates AVCNF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:28 UTC.
| Growth | Solid — Revenue +6% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $372K cash, no debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -26%, ROA -9.3% |
Ownership (AVCNF)
| Insider Ownership | +23.17% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 125.79M |
| Float | 104.29M |
Source: Nexqual, June 10, 2026 at 05:28 UTC.
Leadership (AVCNF)
AVCNF is led by Aras Azadian B.Econ, Co-Founder, CEO & Director, per Nexqual as of June 10, 2026 at 05:28 UTC.
| Co-Founder, CEO & Director | Aras Azadian B.Econ |
|---|---|
| Interim Chief Financial Officer | Nick Hilborn C.A. |
| Executive Vice President of Marketing | Ivana Maric |
| Executive Vice President of Scientific & Medical Affairs | Karolina Urban |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROMJF | Rubicon Organics Inc. | USD 0.32 | ▼ 1.56% |
| BBRRF | Blueberries Medical Co. | USD 0.01 | ▼ 16.41% |
| BMMJ | Body and Mind Inc. | USD 0 | ▲ 0% |
| FFNTF | 4Front Ventures Corp. | USD 0 | ▲ 0% |
| DBCCF | Decibel Cannabis Co Inc. | USD 0.08 | ▼ 9.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:28 UTC. This page is informational and not investment advice.